Truvada, a pill shown to stop transmission of HIV, has cleared a key hurdle before gaining full approval by the U.S. Food and Drug Administration.
Truvada has been on the market since 2004 but has thus far only been given to HIV-positive patients as part of treatment. However, the pill could soon be approved as a preventative measure after clearing an FDA advisory committee, which would be a boon to partners of HIV-positive people.
[On a related note: Holy crap! This is a thing that exists and we’re only now hearing about it? Why haven’t people been shouting from the rooftops about the pill that stops transmission of HIV?]
Not everyone is chuffed to see Truvada prescribed as a preventative tool. Most of the health care professionals who addressed the FDA committee said they feared it could actually have a negative impact by reducing condom use. But used in combination with safe sex practices, it could be another important tool in the long fight against HIV/AIDS.
The drug costs about $1,200 a month and needs to be taken every day in order to be effective.